Cargando…

Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33

BACKGROUND: The infections caused by antibiotic multidrug-resistant bacteria seriously threaten human health. To prevent and cure the infections caused by multidrug-resistant bacteria, new antimicrobial agents are required. Antimicrobial peptides are ideal therapy candidates for antibiotic-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Ruoyu, Teng, Da, Wang, Xiumin, Zhang, Yong, Jiao, Jian, Cao, Xintao, Wang, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373065/
https://www.ncbi.nlm.nih.gov/pubmed/25887810
http://dx.doi.org/10.1186/s12866-015-0389-5
_version_ 1782363286940942336
author Mao, Ruoyu
Teng, Da
Wang, Xiumin
Zhang, Yong
Jiao, Jian
Cao, Xintao
Wang, Jianhua
author_facet Mao, Ruoyu
Teng, Da
Wang, Xiumin
Zhang, Yong
Jiao, Jian
Cao, Xintao
Wang, Jianhua
author_sort Mao, Ruoyu
collection PubMed
description BACKGROUND: The infections caused by antibiotic multidrug-resistant bacteria seriously threaten human health. To prevent and cure the infections caused by multidrug-resistant bacteria, new antimicrobial agents are required. Antimicrobial peptides are ideal therapy candidates for antibiotic-resistant pathogens. However, due to high production costs, novel methods of large-scale production are urgently needed. RESULTS: The novel plectasin-derived antimicrobial peptide-MP1102 gene was constitutively expressed under the control of the GAP promoter. The optimum carbon source and concentration were determined, and 4% glucose (w/v) was initially selected as the best carbon source. Six media were assayed for the improved yield of recombinant MP1102 (rMP1102). The total protein and rMP1102 yield was 100.06 mg/l and 42.83 mg/l, which was accomplished via the use of medium number 1. The peptone and yeast extract from Hongrun Baoshun (HRBS, crude industrial grade, Beijing, China) more effectively improved the total protein and the yield of rMP1102 to 280.41 mg/l and 120.57 mg/l compared to 190.26 mg/l and 78.01 mg/l that resulted from Oxoid (used in the research). Furthermore, we observed that the total protein, antimicrobial activity and rMP1102 yield from the fermentation supernatant increased from 807.42 mg/l, 384,000 AU/ml, and 367.59 mg/l, respectively, in pH5.0 to 1213.64 mg/l, 153,600 AU/ml and 538.17 mg/ml, respectively in pH 6.5 in a 5-l fermenter. Accordingly, the productivity increased from 104464 AU/mg rMP1102 in pH 5.0 to a maximum of 285412 AU/mg rMP1102 in pH 6.5. Finally, the recombinant MP1102 was purified with a cation-exchange column with a yield of 376.89 mg/l, 96.8% purity, and a molecular weight of 4382.9 Da, which was consistent with its theoretical value of 4383 Da. CONCLUSIONS: It’s the highest level of antimicrobial peptides expressed in Pichia pastoris using GAP promoter so far. These results provide an economical method for the high-level production of rMP1102 under the control of the GAP promoter.
format Online
Article
Text
id pubmed-4373065
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43730652015-03-26 Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33 Mao, Ruoyu Teng, Da Wang, Xiumin Zhang, Yong Jiao, Jian Cao, Xintao Wang, Jianhua BMC Microbiol Research Article BACKGROUND: The infections caused by antibiotic multidrug-resistant bacteria seriously threaten human health. To prevent and cure the infections caused by multidrug-resistant bacteria, new antimicrobial agents are required. Antimicrobial peptides are ideal therapy candidates for antibiotic-resistant pathogens. However, due to high production costs, novel methods of large-scale production are urgently needed. RESULTS: The novel plectasin-derived antimicrobial peptide-MP1102 gene was constitutively expressed under the control of the GAP promoter. The optimum carbon source and concentration were determined, and 4% glucose (w/v) was initially selected as the best carbon source. Six media were assayed for the improved yield of recombinant MP1102 (rMP1102). The total protein and rMP1102 yield was 100.06 mg/l and 42.83 mg/l, which was accomplished via the use of medium number 1. The peptone and yeast extract from Hongrun Baoshun (HRBS, crude industrial grade, Beijing, China) more effectively improved the total protein and the yield of rMP1102 to 280.41 mg/l and 120.57 mg/l compared to 190.26 mg/l and 78.01 mg/l that resulted from Oxoid (used in the research). Furthermore, we observed that the total protein, antimicrobial activity and rMP1102 yield from the fermentation supernatant increased from 807.42 mg/l, 384,000 AU/ml, and 367.59 mg/l, respectively, in pH5.0 to 1213.64 mg/l, 153,600 AU/ml and 538.17 mg/ml, respectively in pH 6.5 in a 5-l fermenter. Accordingly, the productivity increased from 104464 AU/mg rMP1102 in pH 5.0 to a maximum of 285412 AU/mg rMP1102 in pH 6.5. Finally, the recombinant MP1102 was purified with a cation-exchange column with a yield of 376.89 mg/l, 96.8% purity, and a molecular weight of 4382.9 Da, which was consistent with its theoretical value of 4383 Da. CONCLUSIONS: It’s the highest level of antimicrobial peptides expressed in Pichia pastoris using GAP promoter so far. These results provide an economical method for the high-level production of rMP1102 under the control of the GAP promoter. BioMed Central 2015-03-03 /pmc/articles/PMC4373065/ /pubmed/25887810 http://dx.doi.org/10.1186/s12866-015-0389-5 Text en © Mao et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mao, Ruoyu
Teng, Da
Wang, Xiumin
Zhang, Yong
Jiao, Jian
Cao, Xintao
Wang, Jianhua
Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
title Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
title_full Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
title_fullStr Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
title_full_unstemmed Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
title_short Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
title_sort optimization of expression conditions for a novel nz2114-derived antimicrobial peptide-mp1102 under the control of the gap promoter in pichia pastoris x-33
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373065/
https://www.ncbi.nlm.nih.gov/pubmed/25887810
http://dx.doi.org/10.1186/s12866-015-0389-5
work_keys_str_mv AT maoruoyu optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33
AT tengda optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33
AT wangxiumin optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33
AT zhangyong optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33
AT jiaojian optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33
AT caoxintao optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33
AT wangjianhua optimizationofexpressionconditionsforanovelnz2114derivedantimicrobialpeptidemp1102underthecontrolofthegappromoterinpichiapastorisx33